Intestinal microbiome changes and stem cell transplantation: Lessons learned

References

• Nishio J, Honda K. Immunoregulation by the gut microbiota. Cell Mol Life Sci 2012; 69:3635-50; PMID:22527722; http://dx.doi.org/10.1007/s00018-012-0993-6
   PubMed Web of Science ®Google Scholar
• Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336:1268-73; PMID:22674334; http://dx.doi.org/10.1126/science.1223490
   PubMed Web of Science ®Google Scholar
• Van Bekkum D, Roodenburg J, Heidt P, Van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974; 52:401-4; PMID:4150164
   PubMed Web of Science ®Google Scholar
• Jones JM, Wilson R, Bealmear PM. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res 1971; 45:577-88; PMID:4396814; http://dx.doi.org/10.2307/3573066
   PubMed Web of Science ®Google Scholar
• Vossen J, Heidt P, Van Den Berg H, Gerritsen E, Hermans J, Dooren L. Prevention of infection and graft-vs.-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Euro J Clin Microbiol Infect Dis 1990; 9:14-23; PMID:2105890; http://dx.doi.org/10.1007/BF01969527
   PubMed Web of Science ®Google Scholar
• Storb R, Prentice RL, Buckner CD, Clift R, Appelbaum F, Deeg J, Doney K, Hansen JA, Mason M, Sanders JE, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings: beneficial effect of a protective environment. N Engl J Med 1983; 308:302-7; PMID:6337323; http://dx.doi.org/10.1056/NEJM198302103080602
   PubMed Web of Science ®Google Scholar
• Armstrong D. Protected environments are discomforting and expensive and do not offer meaningful protection. Am J Med 1984; 76:685-9; PMID:6424468; http://dx.doi.org/10.1016/0002-9343(84)90295-X
   PubMed Web of Science ®Google Scholar
• Bodey GP. Fever and neutropenia: the early years. J Antimicrob Chemother 2009; 63:i3-i13; PMID:19372179; http://dx.doi.org/10.1093/jac/dkp074
   PubMed Web of Science ®Google Scholar
• Van der Waaij D, Berghuis-de Vries J, Lekkerkerk-Van der Wees J. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hygiene 1971; 69:405-11; PMID:4999450; http://dx.doi.org/10.1017/S0022172400021653
   PubMedGoogle Scholar
• Shono Y, Docampo MD, Peled JU, Perobelli SM, Jenq RR. Intestinal microbiota-related effects on graft-versus-host disease. Int J Hematol 2015; 101:428-37; PMID:25812838; http://dx.doi.org/10.1007/s12185-015-1781-5
   PubMed Web of Science ®Google Scholar
• Magurran AE. Measuring biological diversity. Malden, MA: Blackwell Publishing; 2004
   Google Scholar
• Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, Lee YJ, Dubin KA, Socci ND, Viale A, et al. Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Clin Infect Dis 2012; 55:905-14; PMID:22718773; http://dx.doi.org/10.1093/cid/cis580
   PubMed Web of Science ®Google Scholar
• Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, Liu C, West ML, Singer NV, Equinda MJ, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012; 209:903-11; PMID:22547653; http://dx.doi.org/10.1084/jem.20112408
   PubMed Web of Science ®Google Scholar
• Taur Y, Jenq RR, Perales M-A, Littmann ER, Morjaria S, Ling L, No D, Gobourne A, Viale A, Dahi PB, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014; 124:1174-82; PMID:24939656; http://dx.doi.org/10.1182/blood-2014-02-554725
   PubMed Web of Science ®Google Scholar
• Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K, Zhu W, Sporrer D, Hehlgans T, Kreutz M, et al. Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant 2014; 20:640; PMID:24492144; http://dx.doi.org/10.1016/j.bbmt.2014.01.030
   PubMed Web of Science ®Google Scholar
• Weber D, Oefner PJ, Hiergeist A, Koestler J, Gessner A, Weber M, Hahn J, Wolff D, Stämmler F, Spang R, et al. Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. Blood 2015; 126:1723-8; PMID:26209659; http://dx.doi.org/10.1182/blood-2015-04-638858
   PubMed Web of Science ®Google Scholar
• Becattini S, Taur Y, Pamer EG. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med 2016; 22:458-78; PMID:27178527; http://dx.doi.org/10.1016/j.molmed.2016.04.003
   PubMed Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-41
   PubMed Web of Science ®Google Scholar
• Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-98; PMID:19836068; http://dx.doi.org/10.1016/j.cell.2009.09.033
   PubMed Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500:232-6; PMID:23842501; http://dx.doi.org/10.1038/nature12331
   PubMed Web of Science ®Google Scholar
• Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013; 13:790-801; PMID:24096337; http://dx.doi.org/10.1038/nri3535
   PubMed Web of Science ®Google Scholar
• Van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 2010; 6:e1000879; PMID:20523891; http://dx.doi.org/10.1371/journal.ppat.1000879
   PubMed Web of Science ®Google Scholar
• Rolfe RD. Role of volatile fatty acids in colonization resistance to Clostridium difficile. Infect Immun 1984; 45:185-91; PMID:6735467
   PubMed Web of Science ®Google Scholar
• Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504:446-50.
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569-73; PMID:23828891; http://dx.doi.org/10.1126/science.1241165
   PubMed Web of Science ®Google Scholar
• Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504:451-5; PMID:24226773
   PubMed Web of Science ®Google Scholar
• Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu S-R, Sun Y, Rossi C, et al. Corrigendum: Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 2016; 17:1235; PMID:27648549; http://dx.doi.org/10.1038/ni1016-1235b
   PubMed Web of Science ®Google Scholar
• Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MR, Kamboj M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010; 120:4332; PMID:21099116; http://dx.doi.org/10.1172/JCI43918
   PubMed Web of Science ®Google Scholar
• Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 1999; 180:384-90; PMID:10395853; http://dx.doi.org/10.1086/314874
   PubMed Web of Science ®Google Scholar
• Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20:1126-33; PMID:7619987; http://dx.doi.org/10.1093/clinids/20.5.1126
   PubMed Web of Science ®Google Scholar
• Pultz NJ, Stiefel U, Subramanyan S, Helfand MS, Donskey CJ. Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus. J Infect Dis 2005; 191:949-56; PMID:15717271; http://dx.doi.org/10.1086/428090
   PubMed Web of Science ®Google Scholar
• Sava IG, Heikens E, Huebner J. Pathogenesis and immunity in enterococcal infections. Clin Microbiol Infect 2010; 16:533-40; PMID:20569264; http://dx.doi.org/10.1111/j.1469-0691.2010.03213.x
   PubMed Web of Science ®Google Scholar
• Cox CR, Coburn PS, Gilmore MS. Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr Protein Pept Sci 2005; 6:77-84; PMID:15638770; http://dx.doi.org/10.2174/1389203053027557
   PubMed Web of Science ®Google Scholar
• Harris B, Morjaria SM, Littmann ER, Geyer AI, Stover DE, Barker JN, Giralt SA, Taur Y, Pamer EG. Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation. Am J Respir Crit Care Med 2016; 194:450-63; PMID:26886180; http://dx.doi.org/10.1164/rccm.201507-1491OC
   PubMed Web of Science ®Google Scholar
• Collins M, Lawson P, Willems A, Cordoba J, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H, Farrow J. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 1994; 44:812-26; PMID:7981107; http://dx.doi.org/10.1099/00207713-44-4-812
   PubMedGoogle Scholar
• Rajilić-Stojanović M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 2014; 38:996-1047; PMID:24861948; http://dx.doi.org/10.1111/1574-6976.12075
   PubMed Web of Science ®Google Scholar
• Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant 2015; 21:1373-83
   PubMed Web of Science ®Google Scholar
• Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517:205-8; PMID:25337874; http://dx.doi.org/10.1038/nature13828
   PubMed Web of Science ®Google Scholar
• Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013; 501:426-9; PMID:23955152; http://dx.doi.org/10.1038/nature12447
   PubMed Web of Science ®Google Scholar
• Rajili'c-Stojanovi'c M, Heilig HG, Tims S, Zoetendal EG, Vos WM. Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol 2013; 15:1146-59; http://dx.doi.org/10.1111/1462-2920.12023
   Web of Science ®Google Scholar
• Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, Lipuma L, Ling L, Gobourne A, No D, et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013; 81:965-73; PMID:23319552; http://dx.doi.org/10.1128/IAI.01197-12
   PubMed Web of Science ®Google Scholar
• Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007; 20:593-621; PMID:17934076; http://dx.doi.org/10.1128/CMR.00008-07
   PubMed Web of Science ®Google Scholar
• Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107:11971-5; PMID:20566857; http://dx.doi.org/10.1073/pnas.1002601107
   PubMed Web of Science ®Google Scholar
• Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT, Ley RE. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci 2011; 108:4578-85; http://dx.doi.org/10.1073/pnas.1000081107
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, Li Y, Xia Y, Xie H, Zhong H, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015; 17:690-703; http://dx.doi.org/10.1016/j.chom.2015.04.004
   PubMed Web of Science ®Google Scholar
• Huttenhower C, Gevers D, Knight R, Abubucker S, Badger JH, Chinwalla AT, Creasy HH, Earl AM, Fitzgerald MG, Fulton RS, et al. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-14; PMID:22699609; http://dx.doi.org/10.1038/nature11234
   PubMed Web of Science ®Google Scholar
• Beelen DW, Elmaagacli A, Müller KD, Hirche H, Schaefer UW. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 1999; 93:3267-75; PMID:10233878
   PubMed Web of Science ®Google Scholar
• Weber D, Oefner PJ, Dettmer K, Hiergeist A, Koestler J, Gessner A, Weber M, Stämmler F, Hahn J, Wolff D, et al. Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplant 2016; 51:1087-92; PMID:26999466
   PubMed Web of Science ®Google Scholar
• Maccaferri S, Vitali B, Klinder A, Kolida S, Ndagijimana M, Laghi L, Calanni F, Brigidi P, Gibson GR, Costabile A. Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother 2010; 65:2556-65; PMID:20852272
   PubMed Web of Science ®Google Scholar
• Richard P, Felice M, Daeschler T, Richet H, Amador Del Valle G, Moreau P, Milpied N, Harousseau J. Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 1995; 345:1607-9; http://dx.doi.org/10.1016/S0140-6736(95)90117-5
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Sepkowitz KA. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 2002; 34:1524-9; PMID:12015700; http://dx.doi.org/10.1086/340402
   PubMed Web of Science ®Google Scholar
• Cui L, Morris A, Ghedin E. The human mycobiome in health and disease. Genome Med 2013; 5:1; PMID:23311897; http://dx.doi.org/10.1186/gm467
   PubMed Web of Science ®Google Scholar
• Wylie KM, Weinstock GM, Storch GA. Emerging view of the human virome. Transl Res 2012; 160:283-90; PMID:22683423; http://dx.doi.org/10.1016/j.trsl.2012.03.006
   PubMed Web of Science ®Google Scholar
• Minot S, Bryson A, Chehoud C, Wu GD, Lewis JD, Bushman FD. Rapid evolution of the human gut virome. Proc Natl Acad Sci 2013; 110:12450-5; http://dx.doi.org/10.1073/pnas.1300833110
   PubMed Web of Science ®Google Scholar
• Moon C, Stappenbeck TS. Viral interactions with the host and microbiota in the intestine. Curr Opin Immunol 2012; 24:405-10; PMID:22626624
   PubMed Web of Science ®Google Scholar
• Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 2014; 14:405-16; PMID:24854590; http://dx.doi.org/10.1038/nri3684
   PubMed Web of Science ®Google Scholar
• De Vlaminck I, Khush KK, Strehl C, Kohli B, Luikart H, Neff NF, Okamoto J, Snyder TM, Cornfield DN, Nicolls MR, et al. Temporal response of the human virome to immunosuppression and antiviral therapy. Cell 2013; 155:1178-87; PMID:24267896; http://dx.doi.org/10.1016/j.cell.2013.10.034
   PubMed Web of Science ®Google Scholar
• Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Peña J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, et al. Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis. PLoS One 2015; 10:e0139851; PMID:26556047; http://dx.doi.org/10.1371/journal.pone.0139851
   PubMed Web of Science ®Google Scholar
• Memorial Sloan Kettering Cancer Center. Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation [Internet]. 2000; Available from: https://clinicaltrials.gov/ct2/show/NCT02269150
   Google Scholar